Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration

RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the CNIPA in response to an invalidation challenge.

Related Keywords

California ,United States ,Vienna ,Wien ,Austria ,China ,Japan ,Japanese ,Emmanuelle Charpentier ,Japanese Patent Office ,Regents Of The University California ,China National Intellectual Property Administration ,Ers Genomics ,University Of Vienna ,Crispr ,Cas9 ,Genomics ,Na ,Technology ,